HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic control of endosperm amylase activity and gibberellic Acid responses in standard-height and short-statured wheats.

Abstract
In contrast to standard-height wheat genotypes, short-statured wheats having major genes for dwarfness do not show increased seedling growth after treatment with gibberellic acid. Endogenous gibberellic acid induces synthesis of amylase in the endosperm of germinating seeds, but the amount of amylase synthesized is greatly increased by exogenous gibberellic acid treatment in standard-height and in short-statured wheats that have dwarfing genes from the variety "Norin 10." "D6899," which has the "Tom Thumb" gene for height reduction, had about one-fourth of the amylase activity of standard-height and Norin 10-derived, short-statured wheats. This genotype showed little or no increased amylase activity after gibberellic acid treatment. Genetic analyses showed that the amount of amylase synthesized was controlled by a single gene and was dependent on the number of copies of the structural gene present in the endosperm. Dwarfism in wheat may be related to a blockage in gibberellic acid utilization because other workers have found that the amount of endogenous amylase synthesized in Norin 10-derived, short-statured wheats is not growth-limiting, but it is not known if low amylase synthesis is related to dwarfism in the Tom Thumb derivative. No recombinants were recovered in a small population, suggesting that the Tom Thumb gene may pleiotropically affect plant height and the lack of response to gibberellic acid in amylase synthesis and seedling growth.
AuthorsG N Fick, C O Qualset
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 72 Issue 3 Pg. 892-5 (Mar 1975) ISSN: 0027-8424 [Print] United States
PMID16592232 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: